National Institute Of Allergy & Infectious Diseases Director Anthony Fauci: An Interview With "The Pink Sheet" DAILY (Part 2 of 2)
This article was originally published in The Pink Sheet Daily
Manufacturers must "do a lot better than Tamiflu" for pandemic flu therapies, Fauci says.
You may also be interested in...
National Institute Of Allergy & Infectious Diseases Director Anthony Fauci: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
Vaccine manufacturers are experiencing a “Renaissance,” Fauci says.
Sanofi Pasteur, Novartis and GlaxoSmithKline stand to benefit from government's goal of adding 5.3 mil. doses to national stockpile.
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.